paritaprevir/ritonavir-ombitasvir
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for paritaprevir/ritonavir-ombitasvir, covering 2018-10-17 to 2019-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)